Bildkälla: Stockfoto

Alzecure Q3 2024: Business development on the agenda - Redeye

Redeye returns with an update following Alzecure's Q3 report. In relation to this update, we make some adjustments to our deal and pipeline assumptions.

Redeye returns with an update following Alzecure's Q3 report. In relation to this update, we make some adjustments to our deal and pipeline assumptions.
Börsvärldens nyhetsbrev
ANNONSER